Skip to main content


Experimental treatment saves leukemia patient


Experimental treatment saves leukemia patient

April 30, 2014


Source - KING 5 TV

Milton Wright shouldn’t even be alive right now. He spent more than half his life fighting leukemia. “I always knew it was a possibility it could come back,” said Wright. “But I was at the near five-year mark where it was not supposed to come back.” But it did return, for the third time. The news got even worse for this aspiring model when he found out he had become resistant to chemo. That’s when he became the second patient to get Dr. Michael Jensen’s experimental treatment. “What we hope to do is provide, in this trial, opportunity for children and young adults who are at that point in their battle with leukemia in which there are no further options,” said Dr. Jensen with Seattle Children's Ben Towne Foundation.

Contact Information for Press

If you have not worked with Seattle Children’s before, please read our press policy before contacting us.

The best way to reach the public relations team is via email at This inbox is monitored seven days a week, during and after business hours, on weekends and on holidays.

Phone: 206-987-4500
(8:30 a.m. to 5:30 p.m. Pacific time, Monday–Friday only)

Note: This contact information is for members of the media only. For general hospital or research questions, please call the hospital switchboard at 206-987-2000.

Latest News

Training Physicians for Empathy
8.8.14 — HealthLeaders Media

Improving Clinical Management of Stillbirth is an educational session sponsored by the Global Alliance to Prevent Prematurity ... cont.

Remembering Daniel and the Legacy He Left Behind
8.5.14 — On the Pulse Blog

In my last post about “The Fault in Our Stars,” I made a comment about how most patients live, if not thrive after their ... cont.

Seattle Children's program prevents sports injuries
7.31.14 — KING 5 TV

ERs and urgent care facilities see all sorts of sports-related injuries, not only in the summer, but year-round. Seattle ... cont.